Home › Kontrol sa Timbang › Illinois
Pag-aaral pangklinika para sa Kontrol sa Timbang sa Illinois
6 pag-aaral para sa Kontrol sa Timbang ang naghahanap ng mga kalahok sa mga site sa Illinois.
Mga Lungsod sa Illinois
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Cancer Care Specialists of Illinois, Decatur
- Decatur Memorial Hospital, Decatur
- Hope and Healing Clinical Research LLC, Hinsdale
- at 2 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989437Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
- Rush University Medical Center, Chicago
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07015424Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
- Hope and Healing Cancer Services, Hinsdale
- Orchard Healthcare Research, Skokie
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06937177People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Northwestern Memorial Hospital, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07207148A Novel Intervention for Weight Loss in Young Adults
- University of Chicago, Chicago
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 40 · Lahat ng kasarian · Na-update Nob 17, 2025 · NCT06230744DNA Methylation and Vascular Function
- University of Illinois at Chicago, Chicago
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 15, 2025 · NCT03527420Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.